China Strategic Market Access Lead

China is a key growth driver and enabler to the Alexion ambition. China's rare disease market has expanded rapidly over the past five years, while its access and reimbursement framework continues to evolve. Further development of dedicated rare disease policies, funding mechanisms, and an integrated access ecosystem will be important to recognize innovation and support sustainable patient access.The Alexion China strategic Access Lead is expected to play a strategic role in unlocking for China…